Press releases
Access archived Guidant press releases
Access archived BTG press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Aug 9, 2005
(August 9, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has granted a Humanitarian Device Exemption (HDE) approval for the...
-
Aug 2, 2005
(August 2, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the initial activation of bilateral cochlear implants for 14-month-old identical-twin girls at the California Ear...
-
Jul 28, 2005
(July 28, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received the 2005 Best Practices in Logistics Management Gold Award from Logistics Management magazine, a...
-
Jul 19, 2005
(July 19, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for its second quarter ended June 30, 2005. Highlights: Net sales of $1.6 billion, an increase of 11...
-
Jul 11, 2005
(July 11, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that physicians have implanted the 1,000th Precision™ Spinal Cord Stimulation System for the treatment of chronic...
-
Jul 8, 2005
(July 8, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the U.S. launch of its Matrix2™ 360o Detachable Coils, which have been cleared by the U.S. Food and Drug...
-
Jul 7, 2005
(July 7, 2005) -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the second quarter ended June 30, 2005 on Tuesday, July 19, at 11:00...
-
Jul 1, 2005
(July 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that a U.S. District Court jury in Delaware found that Johnson & Johnson's (NYSE: JNJ) CYPHER® drug-eluting stent...
-
Jun 27, 2005
(June 27, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it is voluntarily recalling worldwide all Hemashield® VANTAGE™ Vascular Grafts, which are used in peripheral...
-
Jun 24, 2005
(June 24, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a civil settlement agreement with the U.S. Department of Justice regarding the Department's...
-
Jun 21, 2005
(June 21, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that a jury in a patent infringement case in U.S. District Court in Delaware brought by Johnson & Johnson (NYSE: JNJ)...
-
Jun 20, 2005
(June 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has completed enrollment in the transitional phase of the world's largest drug-eluting stent registry. The...
-
Jun 14, 2005
(June 14, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has completed the final phase of the acquisition of Rubicon Medical Corporation (OTC BB: RMDC). Boston...
-
Jun 9, 2005
(June 9, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in Goldman Sachs' 25th Annual Healthcare Conference, which is being held June 13 -16 in Dana Point, CA....
-
Jun 9, 2005
(June 9, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that a Dutch court has ruled that Cordis Europa N.V. ("Cordis"), a subsidiary of Johnson & Johnson (NYSE: JNJ),...
-
Jun 2, 2005
(June 2, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the completion of the cash tender offer for any and all outstanding shares of common stock of Rubicon Medical...
-
Jun 1, 2005
(June 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that Lucia Luce Quinn has been appointed Executive Vice President of Human Resources. She will be responsible for...
-
May 26, 2005
and Paris, France (May 26, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has enrolled its 400th patient in the world
-
May 25, 2005
and Paris, France (May 25, 2005) -- Boston Scientific Corporation (NYSE: BSX) today provided updated financial estimates for 2005. The Company announced the estimates at a meeting of financial...
-
May 25, 2005
and Paris, France (May 25, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced nine-month sub-population data from its TAXUS V clinical trial that further supports the efficacy of...
-
May 25, 2005
and Paris, France (May 25, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced thirty-day safety data from its ATLAS clinical trial. ATLAS is the first trial using Boston...
-
May 25, 2005
and Paris, France (May 25, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced results from its ARRIVE and Milestone II registries. The results were announced during a symposia...
-
May 24, 2005
and Paris, France (May 24, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced two-year follow-up data from its TAXUS VI clinical trial. The data demonstrated that the safety and...
-
May 24, 2005
and Paris, France (May 24, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced intravascular ultrasound (IVUS) follow-up data from its TAXUS V clinical trial, supporting the safety...
-
May 23, 2005
and Newton, MA (May 23, 2005) -- Boston Scientific Corporation (NYSE: BSX) and Aspect Medical Systems, Inc. (Nasdaq: ASPM) today announced a strategic alliance in which Boston Scientific will...
-
May 23, 2005
(May 23, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved extending the shelf life of its TAXUS® Express2™...
-
May 20, 2005
(May 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the Paris Course on Revascularization (EuroPCR),...
-
May 18, 2005
and Chicago, IL (May 18, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced results of four clinical trials demonstrating patient satisfaction with, and effectiveness of, the ENTERYX®
-
May 12, 2005
(May 12, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Banc of America Securities Health Care Conference 2005, which is being held May 17-19 in Las Vegas....
-
Apr 28, 2005
(April 28, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Deutsche Bank 30th Annual Health Care Conference, which is being held May 2-4 in Baltimore,...
-
Apr 27, 2005
(April 27, 2005) -- Boston Scientific (NYSE: BSX) today announced one-year data from its carotid artery stenting (CAS) clinical trial known as BEACH. The study evaluates the effectiveness of...
-
Apr 20, 2005
(April 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that six articles related to its pivotal TAXUS IV clinical trial were published in the April 19 edition of the...
-
Apr 19, 2005
(April 19, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for its first quarter ended March 31, 2005. Highlights: Net sales of $1.6 billion, an increase of 49...
-
Apr 18, 2005
(April 18, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has acquired TriVascular, Inc., a privately held company based in Santa Rosa, California. Boston Scientific...
-
Apr 18, 2005
(April 18, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has exercised its option to acquire CryoVascular Systems, Inc., a privately held company located in Los Gatos,...
-
Apr 13, 2005
(April 13, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it is now acting as the exclusive distributor of the NexStent™ carotid stent and Monorail™ delivery system in...
-
Apr 12, 2005
(April 12, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that its Quincy, Massachusetts Customer Fulfillment Center has received the prestigious 2004 NorthFace ScoreBoardSM...
-
Apr 12, 2005
(April 12, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that enrollment has begun in its clinical trial known as SYNTAX, which will compare the performance of drug-eluting...
-
Apr 8, 2005
(April 8, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received the Cadence Management Corporation 2004 Award for Customer Excellence in Project Management. This...
-
Apr 7, 2005
(April 7, 2005) -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the first quarter ended March 31, 2005 on Tuesday, April 19, at 11:00...
-
Apr 6, 2005
(April 6, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in SunTrust Robinson Humphrey's 34th Annual Institutional Conference which is being held April 11-12 at the...
-
Apr 6, 2005
(April 6, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has received CE Mark for three large vessel sizes (4.0mm, 4.5mm and 5.0mm) of its TAXUS® Express2™...
-
Apr 5, 2005
(April 5, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved enhancements to the Directions for Use (DFU) of the...
-
Mar 29, 2005
(March 29, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the nationwide release of a revolutionary technology to treat chronic, debilitating pain, a condition affecting...
-
Mar 24, 2005
(March 24, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that a jury in Delaware issued a verdict in a retrial of patent litigation between Boston Scientific and Johnson &...
-
Mar 15, 2005
(March 15, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Quincy Distribution Center as a...
-
Mar 11, 2005
(March 11, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that its Maple Grove, Minnesota manufacturing facility has received the 2005 Shingo Prize for Excellence in...
-
Mar 10, 2005
(March 10, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in SG Cowen & Co.'s 25th Annual Health Care Conference, which is being held March 14 - 17 at the Marriott...
-
Mar 9, 2005
(March 9, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has completed enrollment in its three-year ENTERYX® Procedure clinical trial. The post-approval clinical trial...
-
Mar 6, 2005
and Orlando, FL (March 6, 2005) -- Boston Scientific Corporation (NYSE: BSX) today welcomed the results of Johnson & Johnson's REALITY clinical trial, which reaffirmed the safety and efficacy of...